shelf life of tirzepatide BETRAZINE® + 3 SEP5 v/v How Long Does a Vial

Participants taking Tirzepatide lost up to 15.7% of their body weight, with a significant percentage achieving at least a 5% reduction in body weight

doi: 10.1002/med.22070

1 A KFF survey in May 2024 revealed that one in eight respondents took a GLP-1 drug for any reason, and 43% of patients with type 2 diabetes mellitus either were actively taking a GLP-1 agonist or had taken one in the past

J., Hoyda, T

Texas telehealth platforms typically set a minimum age of 18 even though the FDA approved tirzepatide for adolescents 12+ in late 2024 based on SURMOUNT-Pediatric data

They may also check your blood pressure and blood sugar levels, as these can sometimes cause dizziness